Cardiovascular Research Advance Access first published online on September 19, 2007
This version [Corrected Proof] published online on October 17, 2007
Cardiovascular Research, doi:10.1093/cvr/cvm019
Sarcalumenin alleviates stress-induced cardiac dysfunction by improving Ca2+ handling of the sarcoplasmic reticulum
1 Department of Internal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
2 Department of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
3 Department of Life Science and Medical Bio-Science, Waseda University, Tokyo, Japan
4 Department of Medical Chemistry, Kyoto University Graduate School of Pharmaceutical Science, Kyoto, Japan
5 Department of Cell Biology and Molecular Medicine, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
6 Department of Medicine (Cardiology), New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
* Corresponding author. Tel: +81 45 787 2575; fax: +81 45 788 1470. E-mail address: sminamis{at}yokohama-cu.ac.jp
Aims: Sarcalumenin (SAR) is a Ca2+-binding protein expressed in the longitudinal sarcoplasmic reticulum (SR) of striated muscle cells. Although its Ca2+-binding property is similar to that of calsequestrin, its role in the regulation of Ca2+ cycling remains unclear.
Methods and results: To investigate whether SAR plays an important role in maintaining cardiac function under pressure overload stress, SAR-knockout (SAR-KO) mice were subjected to transverse aortic constriction (TAC). To examine the relation of SAR with cardiac type of SR Ca2+ pump, SERCA2a, we designed cDNA expression using cultured cells. We found that SAR expression was significantly downregulated in hypertrophic hearts from three independent animal models. SAR-KO mice experienced higher mortality than did wild-type (WT) mice after TAC. TAC significantly downregulated SERCA2a protein but not mRNA in the SAR-KO hearts, whereas it minimally did so in hearts from WT mice. Accordingly, SR Ca2+ uptake and cardiac function were significantly reduced in SAR-KO mice after TAC. Then we found that SAR was co-immunoprecipitated with SERCA2a in cDNA-transfected HEK293T cells and mouse ventricular muscles, and that SERCA2a-mediated Ca2+ uptake was augmented when SAR was co-expressed in HEK293T cells. Furthermore, SAR significantly prolonged the half-life of SERCA2a protein in HEK293T cells.
Conclusion: These findings suggest that functional interaction between SAR and SERCA2a enhances protein stability of SERCA2a and facilitates Ca2+ sequestration into the SR. Thus the SAR-SERCA2a interaction plays an essential role in preserving cardiac function under biomechanical stresses such as pressure overload.
KEYWORDS Calcium cycling; Heart failure; Pressure overload; SERCA; Protein stability
Time for primary review: 20 days
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. K. Sahoo, T. Kim, G. B. Kang, J.-G. Lee, S. H. Eom, and D. H. Kim Characterization of Calumenin-SERCA2 Interaction in Mouse Cardiac Sarcoplasmic Reticulum J. Biol. Chem., November 6, 2009; 284(45): 31109 - 31121. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Jiao, Y. Bai, T. Akaike, H. Takeshima, Y. Ishikawa, and S. Minamisawa Sarcalumenin is essential for maintaining cardiac function during endurance exercise training Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H576 - H582. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Murphy, N. T. Larkins, J. P. Mollica, N. A. Beard, and G. D. Lamb Calsequestrin content and SERCA determine normal and maximal Ca2+ storage levels in sarcoplasmic reticulum of fast- and slow-twitch fibres of rat J. Physiol., January 15, 2009; 587(2): 443 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O'Rourke The Ins and Outs of Calcium in Heart Failure Circ. Res., June 6, 2008; 102(11): 1301 - 1303. [Full Text] [PDF] |
||||
![]() |
D. Garcia-Dorado, H. M. Piper, and D. A. Eisner Sarcoplasmic reticulum and mitochondria in cardiac pathophysiology Cardiovasc Res, January 15, 2008; 77(2): 231 - 233. [Full Text] [PDF] |
||||




